COMMISSION IMPLEMENTING REGULATION
(EU) No 1175/2013
of 20 November 2013
approving the active substance benalaxyl-M, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
(Text with EEA relevance)
Article 1
Approval of active substance
Article 2
Re-evaluation of plant protection products
Article 3
Amendments to Implementing Regulation (EU) No 540/2011
Article 4
Entry into force and date of application
ANNEX I
Common Name, Identification Numbers |
IUPAC Name |
Purity(1) |
Date of approval |
Expiration of approval |
Specific provisions |
||||
Benalaxyl-M CAS No 98243-83-5 CIPAC No 766 |
Methyl N-(phenylacetyl)-N-(2,6-xylyl)-D-alaninate |
≥ 950 g/kg |
1 May 2014 |
30 April 2024 |
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on benalaxyl-M, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 3 October 2013 shall be taken into account. In this overall assessment Member States shall pay particular attention to:
Conditions of use shall include risk mitigation measures, where appropriate. |
ANNEX II
Number |
Common Name, Identification Numbers |
IUPAC Name |
Purity(1) |
Date of approval |
Expiration of approval |
Specific provisions |
||||
‘58 |
Benalaxyl-M CAS No 98243-83-5 CIPAC No 766 |
Methyl N-(phenylacetyl)-N-(2,6-xylyl)-D-alaninate |
≥ 950 g/kg |
1 May 2014 |
30 April 2024 |
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on benalaxyl-M, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 3 October 2013 shall be taken into account. In this overall assessment Member States shall pay particular attention to:
Conditions of use shall include risk mitigation measures, where appropriate.’ |